Using imaging data to predict outcomes in ovarian cancer patients
Radiomic biomarkers for clinical decision support that predict patient outcomes in serous ovarian carcinoma
['FUNDING_OTHER'] · H. LEE MOFFITT CANCER CTR & RES INST · NIH-11172693
This study is looking at how regular CT scans can be used to find important clues that help predict how well women with a specific type of ovarian cancer might do after treatment, so doctors can make better choices for their care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | H. LEE MOFFITT CANCER CTR & RES INST (nih funded) |
| Locations | 1 site (TAMPA, UNITED STATES) |
| Trial ID | NIH-11172693 on ClinicalTrials.gov |
What this research studies
This research investigates how computed tomography (CT) images can be transformed into quantitative data to identify biomarkers that predict survival in women with high-grade serous ovarian carcinoma (HGSOC). By analyzing standard CT scans, the study aims to develop non-invasive tools that can help clinicians make better decisions regarding treatment options. The research will focus on a diverse group of patients to ensure the findings are applicable to a wide population. Ultimately, the goal is to improve patient outcomes by identifying those at risk for adverse effects after initial treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with high-grade serous ovarian carcinoma who are undergoing or have undergone first-line chemotherapy.
Not a fit: Patients with other types of ovarian cancer or those who are not receiving treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment plans for ovarian cancer patients, improving survival rates and quality of care.
How similar studies have performed: Previous research has shown promise in using imaging biomarkers for cancer prognosis, suggesting that this approach could be effective.
Where this research is happening
TAMPA, UNITED STATES
- H. LEE MOFFITT CANCER CTR & RES INST — TAMPA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PERES, LAUREN COLE — H. LEE MOFFITT CANCER CTR & RES INST
- Study coordinator: PERES, LAUREN COLE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.